Santos David A

Santos David A is listed in filings as EVP at Rigel Pharmaceuticals, Inc.. This profile follows SEC Form 4 activity through Jun 3, 2026, including sale activity. Recent filings connect the profile to Rigel Pharmaceuticals, Inc. (RIGL). The current snapshot covers public activity from Nov 26, 2024 to Jun 3, 2026. Reported amounts are shown as $26.1K to $205.9K. The page organizes purchases, sales, issuer links, reported share activity, and filing evidence for review as public disclosure data.